July 1, 2013

A drug for treating obesity has become available through a network of about 8,000 retail pharmacies around the country, the drug's manufacturer said.

April 17, 2013

The Food and Drug Administration has approved a modification to a program added to the labeling of an obesity drug to ensure patient safety.

February 1, 2013

Patients who take a drug for losing weight may experience improvement in multiple cardiovascular disease risk factors, according to a new study.

September 19, 2012

Drug maker Vivus has released what it called the first new drug in 13 years for chronic weight management in adults.

July 18, 2012

The Food and Drug Administration has approved a new weight-loss drug made by Vivus, the agency said.

January 31, 2012

The Food and Drug Administration has approved a generic drug for obesity made by Lannett, the drug maker said Tuesday.

October 17, 2011

Vivus has reapplied to the Food and Drug Administration for approval of a drug to treat obesity, the company said Monday.

August 1, 2011

The Food and Drug Administration has approved a generic version of a short-term adjunct treatment for obesity.

July 21, 2011

The Food and Drug Administration has approved a drug for managing obesity made by Lannett.

April 7, 2011

Elite Pharmaceuticals has begun shipping an appetite suppressant for reducing weight in obese patients, the company said Thursday.

February 18, 2011

SUPPLIER NEWS — Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores. Valeant acquired the rights to nonophthalmic topical formulations of Zovirax (acyclovir) from GSK for $300 million through its Canadian subsidiary, Biovail Labs.



February 4, 2011

The Food and Drug Administration has approved a generic weight-loss drug made by Elite Pharmaceuticals.

December 8, 2010

A Food and Drug Administration advisory committee has recommended approval for an investigational diet pill.

October 28, 2010

Vivus found itself foiled in its efforts to market a drug for obesity as the...

March 25, 2010

A Food and Drug Administration committee will review a drug by Vivus for obesity, the...